X
19
Intersect ENT, based in U.S.A, is a pharmaceutical company.
One of their notable products is MOMETASONE FUROATE, with a corresponding application number 209310.
Regulatory Information RX
With a dosage strength 1.35MG
Dosage Form Route IMPLANT; IMPLANTATION
Reference Listed Drug Yes
Approved since 2017-12-08